eGnome has signed a technology transfer agreement with a prominent Japanese biotech firm, focusing on advancing human microbiome technologies. This deal will enhance research capabilities and expand eGnome’s market presence in Japan. The partnership is expected to drive innovation in microbiome analysis and application, benefiting both companies through shared expertise and resources.